For a home health nurse finishing a Tuesday afternoon visit in suburban Pennsylvania, the patient encounter rarely ends when the front door closes. Wound assessments, medication reconciliations, OASIS items, and skilled-need justifications still need to land in the electronic medical record, often after dinner, often unpaid. Scribble Labs Corp., a seed-stage company based in Malvern, Pennsylvania, is betting that an AI assistant a clinician taps once at the start of a visit can absorb most of that documentation burden in real time.
The patient population at the center of this bet is one of the most operationally strained in American medicine: adults receiving skilled care at home. Today the standard of care for documenting those visits is a mix of point-of-care tablets running EMRs like Homecare Homebase, MatrixCare, or WellSky, supplemented by handwritten notes and dictation tools. Charting is widely cited by agency leaders as the leading driver of clinician burnout and turnover in the segment. Ambient AI scribes have moved quickly into physician practices and large health systems, but home health has lagged.
Scribble's product is pitched directly at that gap. According to the company's site, a clinician activates the assistant on their device with a single tap and it then runs in the background during the visit [goscribble.ai]. The company describes itself as building "an AI-powered clinical assistant designed to enhance patient care by streamlining real-time documentation for home health clinicians" [ZoomInfo]. Crucially for the buyer, Scribble says it has built a pricing model tailored to the cost constraints of home health agencies [goscribble.ai].
The bet
The wedge is narrow and deliberate. Rather than competing head-on with general-purpose ambient scribes selling into health systems, Scribble is going after agencies whose clinicians work alone, in homes, on schedules built around windshield time. That focus implies product choices a horizontal scribe would not make: tolerating spotty connectivity, structuring output for home health specific documentation, and pricing per-visit or per-clinician at levels an agency CFO can absorb.
Why it could be big
The addressable market is real. CMS-certified home health agencies serve millions of Medicare beneficiaries each year, and the workforce shortage in home health nursing is acute enough that even modest reductions in documentation time translate into measurable retention and capacity gains. A vertical product purpose-built for home health, sold at agency-friendly prices, is a credible way to win share that horizontal scribes will struggle to defend.
The team and traction
Scribble Labs is led by founder and chief executive Sandeep Banga [ZoomInfo]. The company is reported to be generating under $5 million in revenue [ZoomInfo]. Funding rounds and investors have not been publicly disclosed. The company maintains a presence on YouTube and Instagram where it publishes product walkthroughs aimed at clinical buyers.
The honest counterfactual
What bears will say is that ambient AI scribes are becoming a crowded category, with well-capitalized entrants like Abridge, Suki, and Nuance's DAX Copilot already embedded in large health systems and moving downmarket. What bulls answer is that home health is a genuinely different product, not a feature: the offline-tolerant capture, the OASIS-aware structuring, the per-visit economics, and the relationship sale to agency operators are not where horizontal scribes have invested.
What to watch
The next twelve months should clarify whether Scribble can convert its product focus into named agency customers and a priced, repeatable contract. Worth watching: a first disclosed institutional round, any published pilot data with a home health operator, integrations with the dominant home health EMRs, and whether the company commits to a clinical study. Those are the signals that would move a promising vertical scribe from interesting to durable.